ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

INTRODUCTION: UK guidelines recommend that all early active rheumatoid arthritis (RA) patients are offered combination disease-modifying antirheumatic drugs (DMARDs) and short-term corticosteroids. Anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative RA may differ in their treatment...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Seegobin, Seth D, Ma, Margaret HY, Dahanayake, Chanaka, Cope, Andrew P, Scott, David L, Lewis, Cathryn M, Scott, Ian C
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3979097/
https://ncbi.nlm.nih.gov/pubmed/24433430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4439
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы